Angioimmunoblastic lymphadenopathy with dysproteinemia--lack of a prognostic value of clear cell morphology
- PMID: 9143398
- DOI: 10.1159/000227687
Angioimmunoblastic lymphadenopathy with dysproteinemia--lack of a prognostic value of clear cell morphology
Abstract
It has been suggested that angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is closely related to peripheral T cell lymphoma (PTCL). However, the clinical course of AILD-like PTCL is notoriously unpredictable. A minor portion of patients enjoyed prolonged remission with steroid-only treatments (indolent AILD) while most others died rapidly despite the use of intensive chemotherapy (aggressive AILD). Recently, it has been suggested that histological features such as the presence or absence of clear cells and convoluted cells are of high prognostic value. The validity of this observation was addressed in this study. Eighteen patients who presented between 1977 and 1994 at the National Taiwan University Hospital were retrospectively studied. There were 11 men and 7 women, with a median age of 47 years. Twelve patients had received various regimens of systemic chemotherapy, and the other 3 patients had been treated with steroids alone. Eight patients had indolent AILD and 6 aggressive AILD. The follow-up period in 4 patients was too short to be analyzed. The histopathology of these cases was divided, according to the criteria of Aozasa et al., into group I (neither cells), 4 patients; group II (only convoluted cells), 1 patient, and group III (clear cells with or without convoluted cells), 13 patients. Contrary to others, our data revealed that group III patients were doing better than group I patients. Univariate analysis of other pertinent clinical features, including sex, age, lymphadenopathy, B symptoms, hepatosplenomegaly, hypergammaglobulinemia, elevated serum lactate dehydrogenase, and treatment regimens, revealed none of them to be prognostically relevant. However, patients who had achieved complete remission by steroids or other systemic chemotherapy had a significantly better prognosis than those who had not. Together, these preliminary data suggested that (1) the presence or absence of clear cells and convoluted cells failed to predict the clinical behavior, and (2) induction of complete remission by steroids or other chemotherapeutic agents is an important prognostic index.
Similar articles
-
Angioimmunoblastic lymphadenopathy. Review of 44 patients with emphasis on prognostic behavior.Cancer. 1989 Apr 15;63(8):1625-9. doi: 10.1002/1097-0142(19890415)63:8<1625::aid-cncr2820630832>3.0.co;2-j. Cancer. 1989. PMID: 2924270
-
Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment.Acta Haematol. 1998;99(2):57-64. doi: 10.1159/000040811. Acta Haematol. 1998. PMID: 9554450 Review.
-
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia by local irradiation.ORL J Otorhinolaryngol Relat Spec. 1998 Jul-Aug;60(4):233-5. doi: 10.1159/000027601. ORL J Otorhinolaryngol Relat Spec. 1998. PMID: 9646314
-
Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine.Ann Hematol. 1996 Dec;73(6):295-6. doi: 10.1007/s002770050244. Ann Hematol. 1996. PMID: 9003160
-
[Angioimmunoblastic lymphadenopathy with dysproteinemia: personal experience with 3 cases and review of the literature].Minerva Med. 1993 Dec;84(12):713-8. Minerva Med. 1993. PMID: 8127463 Review. Italian.
Cited by
-
Skin lesions and neutrophilic leukemoid reaction in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of the literature.Clin Case Rep. 2015 Jun;3(6):483-8. doi: 10.1002/ccr3.273. Epub 2015 Apr 29. Clin Case Rep. 2015. PMID: 26185653 Free PMC article.
-
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.J Clin Oncol. 2013 Jan 10;31(2):240-6. doi: 10.1200/JCO.2011.37.3647. Epub 2012 Aug 6. J Clin Oncol. 2013. PMID: 22869878 Free PMC article.
-
No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases.PLoS One. 2014 Mar 20;9(3):e92585. doi: 10.1371/journal.pone.0092585. eCollection 2014. PLoS One. 2014. PMID: 24651162 Free PMC article.
-
Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.Haematologica. 2022 Feb 1;107(2):489-499. doi: 10.3324/haematol.2020.265991. Haematologica. 2022. PMID: 33567811 Free PMC article.
-
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.Blood. 2008 May 1;111(9):4463-70. doi: 10.1182/blood-2007-08-105759. Epub 2008 Feb 21. Blood. 2008. PMID: 18292286 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources